Abstract
Lenalidomide Maintenance Significantly Improves Outcomes Compared to Observation Irrespective of Cytogenetic Risk: Results of the Myeloma XI Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have